Keratoderma palmoplantar spastic paralysis
Keratoderma Palmoplantar Spastic Paralysis (KPP), also known as Charcot-Marie-Tooth disease type 6 (CMT6), is a rare genetic disorder characterized by a combination of palmoplantar keratoderma (thickening of the skin on the palms of the hands and soles of the feet) and spastic paralysis (a form of muscle weakness and stiffness). This condition falls under the broader category of Charcot-Marie-Tooth disease (CMT), which encompasses a group of inherited neurological disorders affecting the peripheral nerves.
Symptoms and Diagnosis[edit | edit source]
The primary symptoms of KPP include severe thickening of the skin on the palms and soles (keratoderma), progressive weakness and stiffness in the legs (spastic paraplegia), and, in some cases, sensory loss. These symptoms typically begin in early childhood but can vary in onset and severity. Diagnosis is based on clinical examination, family history, and genetic testing to identify mutations in specific genes associated with the condition.
Genetics[edit | edit source]
KPP is inherited in an autosomal dominant manner, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder. The condition is linked to mutations in specific genes, although the exact genetic cause can vary among affected individuals. Genetic counseling is recommended for affected families to understand the inheritance pattern and the risks to other family members.
Treatment and Management[edit | edit source]
There is currently no cure for KPP. Treatment focuses on managing symptoms and improving quality of life. This may include the use of moisturizers and keratolytic agents to treat skin symptoms, physical therapy to maintain mobility and reduce muscle stiffness, and, in some cases, medications to manage pain and spasticity. Orthopedic devices may also be recommended to support weakened limbs.
Prognosis[edit | edit source]
The prognosis for individuals with KPP varies depending on the severity of symptoms and the effectiveness of management strategies. While the condition can significantly impact daily activities and mobility, with appropriate care, many individuals can lead active lives.
See Also[edit | edit source]
Keratoderma palmoplantar spastic paralysis Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD